Yesterday’s post was not really about Avastin, but about medical journalism and how patients’ voices are handled by the media. L. Husten, writing on a Forbes blog, cried that the press fawned, inappropriately, over patients’ words at the FDA hearing last week, and that led him to wonder why and if journalists should pay attention to […]
Posted in Breast Cancer, cancer treatment, Empowered Patient, health care costs, Medical News, Oncology (cancer), PolicyTagged Avastin, comparative effectiveness research, evidence-based medicine, informed consent, Larry Husten, medical journalism, medical science, patient advocates, patient voices